TrialThe Journal of infectious diseases2024

Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients.

Sunwen Chou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.